文献速递心脑血管急症

急诊科评估疑似急性冠脉综合征后早期无创心脏检查

Early Noninvasive Cardiac Testing After Emergency Department Evaluation for Suspected Acute Coronary Syndrome.
PubMed 文献 · JAMA Intern Med · 2020-01-01
一句话结论疑似ACS患者急诊评估后早期无创心脏检查与30天内死亡或心梗风险小幅降低相关,但多数患者需治疗人数很大(NNT 250),肌钙蛋白升高者NNT为14。

这项回顾性多中心队列研究纳入2015年1月至2017年12月在急诊就诊、排除急性心梗的胸痛患者79,040例,比较早期(3天内)无创心脏检查与不检查的效果。早期检查使30天内死亡或心梗复合风险绝对降低0.4%(95%CI -0.6%至-0.3%),NNT为250;肌钙蛋白升高亚组NNT为14。作者认为该策略对多数患者可能不是最优,因NNT很大。

要点

  • 疑似ACS患者急诊排除心梗后,30天内死亡或心梗绝对风险<1%,早期无创心脏检查仅小幅降低该风险(绝对降低0.4%,95%CI -0.6%至-0.3%)。
  • 早期无创心脏检查避免1例死亡或心梗的NNT为250,避免1例死亡NNT为500,避免1例心梗NNT为333,避免1例主要不良心血管事件NNT为200(30天内)。
  • 肌钙蛋白升高亚组中,早期无创心脏检查避免1例死亡或心梗的NNT为14。
  • 作者认为,鉴于NNT很大,该策略对多数患者可能不是最优。

适用人群与场景

  • 2015年1月至2017年12月期间在急诊就诊、疑似急性冠脉综合征且已排除急性心梗的胸痛患者,来自Kaiser Permanente南加州综合医疗系统。
  • 患者急诊离院后随访至30天。

研究设计与关键结果

  • 回顾性多中心队列研究,纳入79,040例患者,女性占57.7%,平均年龄57岁(SD 16),其中16,164例(21%)完成了早期无创心脏检查。
  • 30天内死亡或心梗的绝对风险低(<1%);早期无创心脏检查使死亡或心梗复合风险绝对降低0.4%(95%CI -0.6%至-0.3%),死亡绝对降低0.2%(95%CI -0.2%至-0.1%),心梗绝对降低0.3%(95%CI -0.5%至-0.1%),主要不良心血管事件绝对降低0.5%(95%CI -0.7%至-0.3%)。
  • 30天内避免1例死亡或心梗的NNT为250,避免1例死亡的NNT为500,避免1例心梗的NNT为333,避免1例主要不良心血管事件的NNT为200。
  • 亚组分析显示,肌钙蛋白升高患者中避免1例死亡或心梗的NNT为14。

证据类型、等级与局限

  • 证据类型:回顾性多中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,早期无创心脏检查与疑似ACS患者急诊评估后30天内死亡或心梗风险小幅降低相关,但鉴于NNT很大,该策略对多数患者可能不是最优。
  • 肌钙蛋白升高亚组中早期无创心脏检查避免1例死亡或心梗的NNT为14,可能提示该亚组获益更明显,但原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Professional guidelines recommend noninvasive cardiac testing (NIT) within 72 hours of an emergency department (ED) evaluation for suspected acute coronary syndrome. However, there is inexact evidence that this strategy reduces the risk of future death or acute myocardial infarction (MI).

OBJECTIVE: To evaluate the effectiveness of early NIT in reducing the risk of death or acute MI within 30 days.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective, multicenter cohort study within the Kaiser Permanente Southern California integrated health care delivery system compared the effectiveness of early noninvasive cardiac testing vs no testing in patients with chest pain and in whom acute MI was ruled out who presented to an ED from January 2015 to December 2017. Patients were followed up for up to 30 days after emergency department discharge.

EXPOSURES: Noninvasive cardiac testing performed within 3 days of an ED evaluation for suspected acute coronary syndrome.

MAIN OUTCOMES AND MEASURES: The primary outcome was composite risk of death or acute MI, within 30 days of an ED discharge.

RESULTS: A total of 79 040 patients were evaluated in this study, of whom 57.7% were female. The mean (SD) age of the cohort was 57 (16) years, and 16 164 patients (21%) had completed early NIT. The absolute risk of death or MI within 30 days was low (<1%). Early NIT had the minor benefit of reducing the absolute composite risk of death or MI (0.4% [95% CI, -0.6% to -0.3%]), and, separately, of death (0.2% [95% CI, -0.2% to -0.1%]), MI (-0.3% [95% CI, -0.5% to -0.1%]), and major adverse cardiac event (-0.5% [95% CI, -0.7% to -0.3%]). The number needed to treat was 250 to avoid 1 death or MI, 500 to avoid 1 death, 333 to avoid 1 MI, and 200 to avoid 1 major adverse cardiovascular event within 30 days. Subgroup analysis revealed a number needed to treat of 14 to avoid 1 death or MI in the subset of patients with elevated troponin.

CONCLUSIONS AND RELEVANCE: Early NIT was associated with a small decrease in the risk of death or MI in patients admitted to the ED with suspected acute coronary syndrome, but this clinical strategy may not be optimal for most patients given the large number needed to treat.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Kawatkar AA, Sharp AL, Baecker AS, et al. Early Noninvasive Cardiac Testing After Emergency Department Evaluation for Suspected Acute Coronary Syndrome. JAMA Intern Med. 2020. PMID: 33031502. doi:10.1001/jamainternmed.2020.4325

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。